Skip to content

Cerus CERS Debt-to-equity

Debt-to-equity at other companies

CorMedix logo
CorMedixCRMD
0.0×
Haemonetics logo
HaemoneticsHAE
1.6×0.0×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
0.1×-0.1×
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
0.0×
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
1.7×+0.6×
ADMA Biologics logo
ADMA BiologicsADMA
0.5×+0.5×

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Current ratio1.6×-0.7×

Where this comes from

Calculated from Cerus’s reported figures.

Based on the most recent quarter.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's debt-to-equity?
Cerus (CERS) reported debt-to-equity of 0.7× in Q1 2026.
How has Cerus's debt-to-equity changed year-over-year?
Cerus's debt-to-equity decreased by 53.5% year-over-year, from 1.4× to 0.7×.
What is the long-term trend for Cerus's debt-to-equity?
Over 5 years (2020 to 2025), Cerus's debt-to-equity has grown at a 8.2% compound annual growth rate (CAGR), from 0.6× to 0.8×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.